As of 2026-06-26, AstraZeneca PLC (AZN) has a 3-month relative strength percentile of 46 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 1.7%, relative volume 1.64×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
1.7%
ATR(14)14-day EMA
$3.88
ATR%ATR as % of close
2.06%
Beta vs SPY90d rolling
0.28
1-ADR stoprisk from close $188.41
$185.17−1.7%
COMPUTED · AS OF 2026-06-26
Pattern read
AZN is in a stage 2 uptrend, week 1. Currently in a 90-day base; basing ADR 1.7% (broad 1.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 1.8% / 34.9%.
Pure factual computation. Not a recommendation. See stage analysis.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
AZN ranks at the 55th percentile over 1 month, 46th percentile over 3 months, 95th percentile over 6 months, 94th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
AZN is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
AZN currently shows a 20-day average daily range (ADR%) of 1.7%, a 90-day beta versus the S&P 500 of 0.28. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes AZN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what AZN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
No SEC EDGAR filings are linked to AZN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.
§ Seasonality
10y · since 2022
Best monthFebon averageavg +32.10% · 50% win · n 4